Trial Profile
Phase II trial of abraxane administered on a weekly schedule in combination with bevacizumab in metastatic breast cancer
Status:
Active, no longer recruiting
Phase of Trial:
Phase II
Latest Information Update: 10 Nov 2021
Price :
$35
*
At a glance
- Drugs Bevacizumab (Primary) ; Paclitaxel (Primary)
- Indications Advanced breast cancer
- Focus Therapeutic Use
- 19 Oct 2007 Status changed from recruiting to in progress.
- 03 Mar 2007 New trial record.